Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2025-12-25 @ 8:50 PM
Study NCT ID:
NCT04699669
Status:
COMPLETED
Last Update Posted:
2021-01-07
First Post:
2020-12-29
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase 1 Study to Evaluate the Safety and Tolerability of CBL-514 Injection on Convexity or Fullness of Abdominal Subcutaneous Fat in Healthy Volunteers
Sponsor:
Caliway Biopharmaceuticals Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-11-27
Start Date Type:
ACTUAL
Primary Completion Date:
2019-08-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-08-20
Completion Date Type:
ACTUAL
First Submit Date:
2020-12-29
First Submit QC Date:
None
Study First Post Date:
2021-01-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-05
Last Update Post Date:
2021-01-07
Last Update Post Date Type:
ACTUAL